Atlas Trials

Phase I Study of Fruquintinib(HMPL-013) in Patients With Advanced Solid Tumors

Clinical trial NCT01645215 · COMPLETED

Trial details

NCT number
NCT01645215
Sponsor
Hutchison Medipharma Limited
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Tumor
Start date
2011-01-01
Primary completion
2012-10-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.